drugset / Trial / NCT00558792

Coronary MDCTA With Iopamidol Injection 370

NCT00558792

Phase 2 Completed 210 enrolled Bracco Diagnostics, Inc
RandomizedParallel-groupTriple-blindDiagnostic

Summary

Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.

Timeline

Start
2007-11
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Iopamidol Diagnostic / imaging agent 70 ml
Subject Iopamidol Diagnostic / imaging agent 80 ml
Subject Iopamidol Diagnostic / imaging agent 90 ml

Indications